Lateralized ante mortem and post mortem pathology in a case of Lewy body disease with corticobasal syndrome
Abstract Introduction Lewy body diseases are pathologically characterized by α‐synuclein pathology. Alzheimer's disease (AD) co‐pathology can influence phenotypes. In vivo AD biomarkers can suggest the presence of this co‐pathology in unusual cases, but pathological validation remains essential...
Main Authors: | David G. Coughlin, H. Branch Coslett, Claire Peterson, Jeffrey S. Phillips, Corey McMillan, Edward B. Lee, John Q. Trojanowski, Murray Grossman, David J. Irwin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
Subjects: | |
Online Access: | https://doi.org/10.1002/trc2.12294 |
Similar Items
-
Case Report: Concomitant Alzheimer's and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome
by: Michaela Kaiserová, et al.
Published: (2021-11-01) -
Corticobasal degeneration and corticobasal syndrome: A review
by: Vasilios C. Constantinides, et al.
Published: (2019-01-01) -
Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
by: P.G. Foulds, et al.
Published: (2012-01-01) -
Pharmacological interventions in corticobasal degeneration: a review
by: Leonardo Caixeta, et al.
Published: (2020-09-01) -
Corticobasal syndrome: A diagnostic conundrum
by: Jacy Bezerra Parmera, et al.